239 related articles for article (PubMed ID: 12606761)
1. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
[TBL] [Abstract][Full Text] [Related]
2. Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1.
Madeja M; Steffen W; Mesic I; Garic B; Zhorov BS
J Biol Chem; 2010 Oct; 285(44):33898-905. PubMed ID: 20709754
[TBL] [Abstract][Full Text] [Related]
3. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.
Wang Z; Wang S; Li J; Jiang X; Wang N
J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818
[TBL] [Abstract][Full Text] [Related]
4. Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
Mergenthaler J; Haverkamp W; Hüttenhofer A; Skryabin BV; Musshoff U; Borggrefe M; Speckmann EJ; Breithardt G; Madeja M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):472-80. PubMed ID: 11330342
[TBL] [Abstract][Full Text] [Related]
5. The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS
Mol Pharmacol; 2004 Nov; 66(5):1201-12. PubMed ID: 15308760
[TBL] [Abstract][Full Text] [Related]
6. Influence of non-P region domains on selectivity filter properties in voltage-gated K+ channels.
Immke D; Kiss L; LoTurco J; Korn SJ
Recept Channels; 1998; 6(3):179-88. PubMed ID: 10100326
[TBL] [Abstract][Full Text] [Related]
7. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
Islas LD; Sigworth FJ
J Gen Physiol; 1999 Nov; 114(5):723-42. PubMed ID: 10539976
[TBL] [Abstract][Full Text] [Related]
8. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action.
Nilsson J; Madeja M; Arhem P
Mol Pharmacol; 2003 Jun; 63(6):1417-29. PubMed ID: 12761353
[TBL] [Abstract][Full Text] [Related]
9. Structural elements determining activation kinetics in Kv2.1.
Scholle A; Koopmann R; Leicher T; Ludwig J; Pongs O; Benndorf K
Recept Channels; 2000; 7(1):65-75. PubMed ID: 10800777
[TBL] [Abstract][Full Text] [Related]
10. Modification of delayed rectifier potassium currents by the Kv9.1 potassium channel subunit.
Richardson FC; Kaczmarek LK
Hear Res; 2000 Sep; 147(1-2):21-30. PubMed ID: 10962170
[TBL] [Abstract][Full Text] [Related]
11. Role of the S2 and S3 segment in determining the activation kinetics in Kv2.1 channels.
Koopmann R; Scholle A; Ludwig J; Leicher T; Zimmer T; Pongs O; Benndorf K
J Membr Biol; 2001 Jul; 182(1):49-59. PubMed ID: 11426299
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and functional characterization of a novel delayed rectifier potassium channel from channel catfish (Ictalurus punctatus): expression in taste buds.
Kang J; Teeter JH; Brazier SP; Nguyen ND; Chang CC; Puchalski RB
J Neurochem; 2001 Mar; 76(5):1465-74. PubMed ID: 11238731
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.
Shieh CC; Kirsch GE
Biophys J; 1994 Dec; 67(6):2316-25. PubMed ID: 7696472
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
Kurata HT; Soon GS; Eldstrom JR; Lu GW; Steele DF; Fedida D
J Biol Chem; 2002 Aug; 277(32):29045-53. PubMed ID: 12021261
[TBL] [Abstract][Full Text] [Related]
15. Open channel block of HERG K(+) channels by vesnarinone.
Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
[TBL] [Abstract][Full Text] [Related]
16. Functional differences of a Kv2.1 channel and a Kv2.1/Kv1.2S4-chimera are confined to a concerted voltage shift of various gating parameters.
Koopmann R; Benndorf K; Lorra C; Pongs O
Recept Channels; 1997; 5(1):15-28. PubMed ID: 9272573
[TBL] [Abstract][Full Text] [Related]
17. The Roles of N- and C-terminal determinants in the activation of the Kv2.1 potassium channel.
Ju M; Stevens L; Leadbitter E; Wray D
J Biol Chem; 2003 Apr; 278(15):12769-78. PubMed ID: 12560340
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels.
Tao H; Chen JJ; Xiao YC; Wu YY; Su HB; Li D; Wang HY; Deng MC; Wang MC; Liu ZH; Liang SP
Biochemistry; 2013 Oct; 52(42):7439-48. PubMed ID: 24044413
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Zhang ZH; Lee YT; Rhodes K; Wang K; Argentieri TM; Wang Q
Brain Res Mol Brain Res; 2003 Jul; 115(1):29-38. PubMed ID: 12824052
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of Kv6.2 a new gamma-subunit of voltage-gated potassium channel.
Zhu XR; Netzer R; Böhlke K; Liu Q; Pongs O
Recept Channels; 1999; 6(5):337-50. PubMed ID: 10551266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]